Bridging Lipid Metabolism and Innate Host Defense
- 15 October 2014
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 6 (258) , 258fs41
Abstract
Host- and pathogen-derived lipids share clearance mechanisms that pinpoint PCSK9 as a plausible target for the treatment of some patients with sepsis.Keywords
This publication has 11 references indexed in Scilit:
- PCSK9 is a critical regulator of the innate immune response and septic shock outcomeScience Translational Medicine, 2014
- Why have clinical trials in sepsis failed?Trends in Molecular Medicine, 2014
- Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe SepsisJAMA, 2013
- Genomic responses in mouse models poorly mimic human inflammatory diseasesProceedings of the National Academy of Sciences, 2013
- Cholesterol-lowering blockbuster candidates speed into Phase III trialsNature Reviews Drug Discovery, 2012
- Crosstalk between reverse cholesterol transport and innate immunityTrends in Endocrinology & Metabolism, 2012
- Cancer Biomarkers—An Invitation to the TableScience, 2006
- NEUTRALIZATION OF TUMOR NECROSIS FACTOR IN PRECLINICAL MODELS OF SEPSISShock, 2005
- Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis SyndromeAnnals of Internal Medicine, 1993
- Genetic and Environmental Influences on Premature Death in Adult AdopteesNew England Journal of Medicine, 1988